Organogenesis Holdings

Parent (1 child)

We are a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. Our products have been shown through clinical studies to support and in some cases accelerate tissue healing and improve patient outcomes. We are advancing the standard of care in the healing process through multiple breakthroughs in tissue engineering and cell therapy. Our solutions address large and growing markets driven by aging demographics and increases in comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease and smoking. We offer our differentiated products and in-house customer support to a wide range of health care customers. Our mission is to provide integrated healing solutions that substantially improve medical outcomes and the lives of patients while lowering the overall cost of care. For more info, please visit us at http://www.organogenesis.com.

Apligraf, Dermagraft, PuraPly, PuraPlyAM, NuShield, Bio-active wound healing, Soft tissue regeneration

Canton, MA
United States